Reevaluating Mask Effectiveness: Insights From Evidence-Based Medicine and Clinical Trials

During the COVID-19 pandemic, masks were widely promoted and mandated as a key measure to help reduce the transmission of SARS-CoV-2. These policies were primarily informed by laboratory evidence demonstrating the effectiveness of particle filtration, alongside observational studies. While several meta-analyses have indicated that masks may contribute to reducing viral transmission, many of these analyses rely heavily on observational data. There also appears to be a trend where the inclusion of more randomized controlled trials in a meta-analysis is associated with a lower estimate of mask effectiveness. It is important to recognize that success in laboratory settings does not always directly translate to the same outcomes in clinical trials or real-world conditions. This phenomenon is often seen in drug development, where therapies with promising mechanistic evidence may not always perform as expected in trials. In this regard, masks share similarities with other interventions that, while theoretically sound, require further testing in varied contexts to fully assess their real-world impact.